Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma

NCT00411086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: Rituximab
BIOLOGICAL: Sargramostim (GM-CSF)

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]